14 Stocks Under $5 with Highest Upside Potential

Page 11 of 13

3. Compass Therapeutics Inc. (NASDAQ:CMPX)

​Analyst Upside: 151.26%

Share Price: $3.98

Number of Hedge Fund Holders: 15

Compass Therapeutics Inc. (NASDAQ:CMPX) is one of the best stocks under $5 with highest upside potential. Compass Therapeutics Inc. (NASDAQ:CMPX) received a rating update from Piper Sandler analyst Biren Amin on October 27, who maintained a Buy rating on the stock with a $12 price target.

Similarly, LifeSci Capital analyst Charles Zhu also expressed bullish sentiments for Compass Therapeutics Inc. (NASDAQ:CMPX) on October 17, reiterating a Buy rating with a $10 price target.

Zhu cited the promising progress of the company’s COMPANION-002 trial, which is testing tovecimig for second-line biliary tract cancer (BTC) patients. The trial exhibited potential clinical benefits with a median follow-up of around 19 months, which the analyst considers notable since it exceeds the overall survival rates shown by other similar studies.

In addition to this positive outlook for the treatment, Zhu expects the anticipated pricing strategy for tovecimig to offer financial upside, with both domestically and internationally ongoing regulatory engagements further expected to bolster future growth prospects.

Compass Therapeutics Inc. (NASDAQ:CMPX) is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics. The company’s platform includes human display for antibody tuning, common light chain-focused antibody discovery, stitchmabs, and highly modular and manufacturable bispecific candidates.

Page 11 of 13